Is Aethlon Medical Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: AEMD) stock is to Buy AEMD stock.
Out of 1 analyst, 0 (0%) are recommending AEMD as a Strong Buy, 1 (100%) are recommending AEMD as a Buy, 0 (0%) are recommending AEMD as a Hold, 0 (0%) are recommending AEMD as a Sell, and 0 (0%) are recommending AEMD as a Strong Sell.
What is AEMD's revenue growth forecast for 2025-2025?
(NASDAQ: AEMD) Aethlon Medical's forecast annual revenue growth rate of 85.26% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.18%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.92%.
Aethlon Medical's revenue in 2024 is $574,245.
In 2025, AEMD is forecast to generate $4,192,638 in revenue, with the lowest revenue forecast at $4,192,638 and the highest revenue forecast at $4,192,638.
What is AEMD's forecast return on assets (ROA) for 2025-2027?
(NASDAQ: AEMD) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of N/A.
What is AEMD's Price Target?
According to 1 Wall Street analyst that have issued a 1 year AEMD price target, the average AEMD price target is $10.00, with the highest AEMD stock price forecast at $10.00 and the lowest AEMD stock price forecast at $10.00.
The Wall Street analyst predicted that Aethlon Medical's share price could reach $10.00 by Mar 4, 2025. The average Aethlon Medical stock price prediction forecasts a potential upside of 565.34% from the current AEMD share price of $1.50.
What is AEMD's forecast return on equity (ROE) for 2025-2027?
(NASDAQ: AEMD) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.